AACR Annual Meeting 2019: A Record Year for Clinical Trials Presentations
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
Tag: Clinical trials
Over the course of AACR Annual Meeting 2019, there were 213 presentations on incredibly exciting clinical trials. This is...
In the past couple of decades, progress against cancer has created a new generation of survivors. Today, more than...
About 80 percent of lung cancers are non-small cell lung cancers (NSCLC), and about 15 to 20 percent of...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
Patient enrollment in clinical trials has long been on the minds of oncologists and researchers. In 1990, fewer than...
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...